文献速递血栓与止血

急性巨细胞病毒感染相关抗PF4介导的血小板减少症和血栓形成兼具HIT样与VITT样特征

Anti-PF4 mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both HIT-like and VITT-like characteristics.
PubMed 文献 · Br J Haematol · 2025-04-29

本文报道一例急性巨细胞病毒感染后发生抗血小板因子4(PF4)相关免疫性血小板减少和血栓形成(PITT)的患者,其抗体克隆型和PF4表位与VITT不同,且抗体可作为副蛋白检测到。作者认为,对于血小板减少和血栓形成患者,即使无疫苗或肝素暴露史,只要符合英国血液学会专家组定义的VITT标准,均应考虑PITT。

要点

  • 急性巨细胞病毒感染后可发生抗PF4介导的PITT。
  • 该例抗体克隆型及PF4表位与VITT不同,且以副蛋白形式检出。
  • 无疫苗或肝素暴露但符合VITT标准者应考虑PITT。

核心结论

  • 急性巨细胞病毒感染后可出现抗PF4介导的PITT,其抗体克隆型和PF4表位与VITT不同,且抗体可作为副蛋白检测到。

研究设计与样本

  • 本文为病例报告,描述一例急性巨细胞病毒感染后发生PITT的患者。

主要发现

  • 该例患者急性巨细胞病毒感染后发生PITT,抗体克隆型和PF4表位与VITT中识别的不同。
  • 该例抗体可作为副蛋白检测到。

关键数值与推荐

  • 对于血小板减少和血栓形成患者,即使无 preceding vaccination 或肝素暴露,只要符合英国血液学会专家组定义的VITT标准,均应考虑PITT。

临床怎么用

  • 作者认为,血小板减少和血栓形成患者即使无疫苗或肝素暴露史,只要符合英国血液学会专家组定义的VITT标准,均应考虑PITT。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is one of several anti-platelet factor 4 (anti-PF4)-associated immune thrombocytopenia and thrombosis (PITT) syndromes. As well as following adenoviral vector vaccines, VITT has recently been described following acute adenovirus infection. We describe a patient with PITT following acute cytomegalovirus infection. The antibody clonotype and PF4 epitopes were distinct from those identified in VITT, and they were detectable as a paraprotein. PITT should be considered in all patients with thrombocytopenia and thrombosis, even without preceding vaccination or heparin, but who otherwise meet the VITT criteria defined by the British Society of Haematology Expert Panel.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Nicolson PLR, Montague SJ, Buka RJ, et al. Anti-PF4 mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both HIT-like and VITT-like characteristics. Br J Haematol. 2025. PMID: 40298004. doi:10.1111/bjh.20092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。